← All trials
NCT01828385
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2012
- Primary completion
- Feb 1, 2013
- Completion date
- Feb 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Federal University of Rio de JaneiroLead sponsor
- Hospital Federal de BonsucessoOverall official - principal investigator
- Federal University of Rio de JaneiroStudy director
- Hospital Federal de BonsucessoCollaborator
- Federal University of Rio de JaneiroReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.